Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Icade Capital/Financing Update 2019

Nov 15, 2019

1424_iss_2019-11-15_a6ec43d9-8aa2-4964-9df3-77baa5c9cdba.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

PRESS RELEASE Issy-les-Moulineaux, November 15, 2019, 5:45 p.m.

ICADE SANTE CONTINUES TO EXPAND WITH A NEW INVESTMENT FOR €194 MILLION (INCLUDING DUTIES)

Icade Santé today signed an agreement with private hospital group Vivalto Santé to acquire the Confluent Group (Nouvelles Cliniques Nantaises), which owns the Confluent private hospital located in Nantes. Following this transaction, Icade Santé will own the property assets of the Confluent private hospital, worth a total of €194 million.

The Confluent private hospital covers close to 58,000 sq.m, being one the largest private hospitals with 509 beds and places and 28 operating rooms. The facility took 4th place in Le Point's 2019 annual ranking of the best public and private hospitals in France.

The operation of this site will be taken over concurrently by Vivalto Group, a leading French private hospital operator. A 12-year lease with no break option has been entered into between the operator and Icade Santé.

This acquisition, which is part of Icade Santé's ambitious expansion plan including the goal of investing €1 billion in France by 2022, strengthens the partnership between Icade Santé and Vivalto Santé with a third facility leased to this operator. In addition, it bolsters Icade Santé's position as the leader in healthcare real estate in France, with a portfolio encompassing 128 assets and worth a total of €4.9 billion (excluding duties).

ABOUT ICADE

Building for every future

As an investor and a developer, Icade is an integrated real estate player which designs innovative real estate products and services adapted to new urban lifestyles and habits. By placing corporate social responsibility and innovation at the core of its strategy, Icade is working closely with stakeholders and users in the cities local authorities and communities, companies and employees, institutions and associations… As an office and healthcare property investor (portfolio value of €11.7bn as of 06/30/19 on a proportionate consolidation basis) and as a property developer (2018 economic revenues of €1,251m), Icade has been able to reinvent the real estate business and foster the emergence of tomorrow's greener, smarter and more responsible cities. Icade is a significant player in the Greater Paris area and major French cities. Icade is listed on Euronext Paris as a French Listed Real Estate Investment Company (SIIC). Its leading shareholder is the Caisse des dépôts Group.

ABOUT ICADE SANTÉ

With a portfolio of €4.5 billion (on a full consolidation basis) as of June 30, 2019, Icade Santé is the leading healthcare property investor in France. A 56.86% owned subsidiary of the Icade Group, Icade Santé draws on its proven expertise, its long-term shareholders as well as its extensive knowledge of the real estate value chain. Since 2017, Icade Santé has pursued a strategy of diversification into the nursing home segment.

The text of this press release is available on the Icade website: www.icade.fr/en/

CONTACTS
Anne-Sophie Lanaute
Head of Financial Communication and Investor Relations
Charlotte Pajaud-Blanchard
Press Relations Manager
+33(0)1 41 57 70 29 +33(0)1 41 57 71 19
[email protected] [email protected]